Correlation Between Mink Therapeutics and Weibo Corp
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Weibo Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Weibo Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Weibo Corp, you can compare the effects of market volatilities on Mink Therapeutics and Weibo Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Weibo Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Weibo Corp.
Diversification Opportunities for Mink Therapeutics and Weibo Corp
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Mink and Weibo is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Weibo Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Weibo Corp and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Weibo Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Weibo Corp has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Weibo Corp go up and down completely randomly.
Pair Corralation between Mink Therapeutics and Weibo Corp
Given the investment horizon of 90 days Mink Therapeutics is expected to generate 4.55 times more return on investment than Weibo Corp. However, Mink Therapeutics is 4.55 times more volatile than Weibo Corp. It trades about 0.08 of its potential returns per unit of risk. Weibo Corp is currently generating about 0.03 per unit of risk. If you would invest 732.00 in Mink Therapeutics on December 1, 2024 and sell it today you would earn a total of 163.00 from holding Mink Therapeutics or generate 22.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Mink Therapeutics vs. Weibo Corp
Performance |
Timeline |
Mink Therapeutics |
Weibo Corp |
Mink Therapeutics and Weibo Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mink Therapeutics and Weibo Corp
The main advantage of trading using opposite Mink Therapeutics and Weibo Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Weibo Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Weibo Corp will offset losses from the drop in Weibo Corp's long position.Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Weibo Corp vs. YY Inc Class | Weibo Corp vs. DouYu International Holdings | Weibo Corp vs. Tencent Music Entertainment | Weibo Corp vs. Autohome |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |